Patent | Date |
---|
Methods And Compositions For Treating Anxiety Disorders Or Symptoms Thereof App 20140243363 - Crain; Steven ;   et al. | 2014-08-28 |
Methods and compositions for treating anxiety disorders or symptoms thereof Grant 8,741,319 - Crain , et al. June 3, 2 | 2014-06-03 |
Methods And Compositions For Treating Anxiety Disorders Or Symptoms Thereof App 20140127328 - Crain; Steven ;   et al. | 2014-05-08 |
Methods and compositions for treating distress dysfunction and enhancing safety and efficacy of specific medications Grant 08617577 - | 2013-12-31 |
Methods and compositions for treating distress dysfunction and enhancing safety and efficacy of specific medications Grant 8,617,577 - Crain , et al. December 31, 2 | 2013-12-31 |
Novel Method To Improve The Safety And Efficacy Of Caffeine App 20130197015 - CRAIN; Steven ;   et al. | 2013-08-01 |
Methods And Compositions For Treating Distress Dysfunction And Enhancing Safety And Efficacy Of Specific Medications App 20130156874 - Crain; Steven ;   et al. | 2013-06-20 |
Methods and compositions for treating distress dysfunction and enhancing safety and efficacy of specific medications Grant 8,372,414 - Crain , et al. February 12, 2 | 2013-02-12 |
Methods And Compositions For Treating Distress Dysfunction And Enhancing Safety And Efficacy Of Specific Medications App 20120237570 - Crain; Steven ;   et al. | 2012-09-20 |
Methods and compositions for treating distress dysfunction and enhancing safety and efficacy of specific medications Grant 8,202,525 - Crain , et al. June 19, 2 | 2012-06-19 |
Methods And Compositions For Treating Distress Dysfunction And Enhancing Safety And Efficacy Of Specific Medications App 20110159048 - Crain; Steven ;   et al. | 2011-06-30 |
Method For Treating Pain Or Opioid Dependence Using A Specific Type Of Non-opioid Agent In Combination With A Selective Excitatory-opioid-receptor Inactivator App 20100203084 - Crain; Stanley M. ;   et al. | 2010-08-12 |
Methods for increasing analgesic potency and attenuating adverse excitatory effects of bimodally-acting opioid agonists by inhibiting GM1-ganglioside App 20100015147 - Crain; Stanley M. ;   et al. | 2010-01-21 |
Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists Grant 7,026,329 - Crain , et al. April 11, 2 | 2006-04-11 |
Compositions and methods for enhancing analgesic potency of tramadol and attenuating its adverse side effects App 20060052389 - Crain; Stanley M. ;   et al. | 2006-03-09 |
Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists App 20050181974 - Crain, Stanley M. ;   et al. | 2005-08-18 |
Method and composition for treating irritable bowel syndrome using low doses of opioid receptor antagonists App 20050101622 - Crain, Stanley M. ;   et al. | 2005-05-12 |
Compositions and methods for enhancing analgesic potency of tramadol and attenuating its adverse side effects Grant 6,765,010 - Crain , et al. July 20, 2 | 2004-07-20 |
Method and composition for treating irritable bowel syndrome using low doses of opioid receptor antagonists Grant 6,737,400 - Crain , et al. May 18, 2 | 2004-05-18 |
Methods for increasing analgesic potency and attenuating adverse excitatory effects of bimodally-acting opioid agonists by inhibiting GM1-ganglioside App 20040087607 - Crain, Stanley M. ;   et al. | 2004-05-06 |
Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists App 20030232744 - Crain, Stanley M. ;   et al. | 2003-12-18 |
Compositions and methods for enhancing analgesic potency of tramadol and attenuating its adverse side effects App 20030148941 - Crain, Stanley M. ;   et al. | 2003-08-07 |
Method and composition for treating irritable bowel syndrome using low doses of opioid receptor antagonists App 20020173466 - Crain, Stanley M. ;   et al. | 2002-11-21 |
Methods for increasing analgesic potency and attenuating adverse excitatory effects of bimodally -acting opioid agonists by inhibiting GM1-ganglioside App 20020137761 - Crain, Stanley M. ;   et al. | 2002-09-26 |
Method Of Simultaneously Enhancing Analgesic Potency And Attenuating Dependence Liability Caused By Morphine And Other Bimodally-acting Opioid Agonists App 20020094947 - Crain, Stanley M. ;   et al. | 2002-07-18 |
Method and composition for treating irritable bowel syndrome using low doses of opioid receptor antagonists Grant 6,395,705 - Crain , et al. May 28, 2 | 2002-05-28 |
Method and simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists Grant 6,362,194 - Crain , et al. March 26, 2 | 2002-03-26 |
Method and composition for treating irritable bowel syndrome using low doses of opioid receptor antagonists App 20010018413 - Crain, Stanley M. ;   et al. | 2001-08-30 |
Method Of Simultaneously Enhancing Analgesic Potency And Attenuating Adverse Side Effects Caused By Tramadol And Other Bimodally-acting Opioid Agonists App 20010006967 - CRAIN, STANLEY M. ;   et al. | 2001-07-05 |
Method and composition for treating irritable bowel syndrome using low doses of opioid receptor antagonists Grant 6,194,382 - Crain , et al. February 27, 2 | 2001-02-27 |
Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists Grant 6,096,756 - Crain , et al. August 1, 2 | 2000-08-01 |
Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opioid agonists Grant RE36,547 - Crain , et al. February 1, 2 | 2000-02-01 |
Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists Grant 5,767,125 - Crain , et al. June 16, 1 | 1998-06-16 |
Method for identification of low/non-addictive opioid analgesics and the use of said analgesics for treatment of opioid addiction Grant 5,624,932 - Qin , et al. April 29, 1 | 1997-04-29 |
Use of excitatory opioid receptor antagonists to prevent growth factor-induced hyperalgesia Grant 5,585,348 - Crain , et al. December 17, 1 | 1996-12-17 |
Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists Grant 5,580,876 - Crain , et al. December 3, 1 | 1996-12-03 |
Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by exogenous and endogenous opiod agonists Grant 5,512,578 - Crain , et al. April 30, 1 | 1996-04-30 |
Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other opioid agonists Grant 5,472,943 - Crain , et al. December 5, 1 | 1995-12-05 |